Related Experiment Video

Updated: Aug 11, 2026

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

Induction of genes involved in cell cycle progression by interleukin-4

Christine McDonald1, Sarah Vanscoy, Patrick Hearing

  • 1Department of Pathology, Stony Brook University, Stony Brook, NY 11794, USA.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|February 3, 2005
PubMed

Insights

Interleukin-4 (IL-4) promotes T lymphocyte proliferation by upregulating cell cycle genes via Stat6 and PI3K pathways. Activated Stat6 dimers bind E2F sites, regulating gene expression crucial for immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Interleukin-4 (IL-4) is a key cytokine mediating immune responses, driving cellular processes like differentiation, fusion, and proliferation.
  • T lymphocyte proliferation is essential for establishing an effective adaptive immune response.

Purpose of the Study:

  • To investigate the molecular mechanisms by which IL-4 induces T lymphocyte proliferation.
  • To identify the specific signaling pathways and transcription factors involved in IL-4-mediated cell cycle gene regulation.

Main Methods:

  • Analysis of transcriptional induction of cell cycle genes (Cdc25A, MCM family) in response to IL-4.
  • Investigating the roles of Signal Transducer and Activator of Transcription 6 (Stat6) and Phosphatidylinositol 3-Kinase (PI3K) pathways.
  • Assessing the binding of IL-4-activated Stat6 dimers to E2F target sites and their effect on gene expression.

Main Results:

  • IL-4 induces T lymphocyte proliferation through coordinated transcriptional induction of Cdc25A and MCM family genes.
  • Stat6 activation is a primary driver of this gene induction, with PI3K playing a complementary role.
  • IL-4-activated Stat6 dimers bind to a subset of E2F target sites, thereby stimulating gene expression.

Conclusions:

  • The Stat6 signaling pathway is critical for regulating a subset of E2F-responsive genes involved in cell cycle progression.
  • IL-4 utilizes Stat6 and PI3K signaling to promote T lymphocyte proliferation by modulating cell cycle gene expression.
  • These findings elucidate a novel mechanism for IL-4 in immune response regulation.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...